Abstract
Original language | English |
---|---|
Journal | Osteoarthritis and Cartilage |
Early online date | 2023 |
DOIs | |
Publication status | E-pub ahead of print - 2023 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Evaluating Osteoarthritis Management Programs : outcome domain recommendations from the OARSI Joint Effort Initiative. / Allen, K. D.; Huffman, K.; Cleveland, R. J. et al.
In: Osteoarthritis and Cartilage, 2023.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Evaluating Osteoarthritis Management Programs
T2 - outcome domain recommendations from the OARSI Joint Effort Initiative
AU - Allen, K. D.
AU - Huffman, K.
AU - Cleveland, R. J.
AU - van der Esch, M.
AU - Abbott, J. H.
AU - Abbott, A.
AU - Bennell, K.
AU - Bowden, J. L.
AU - Eyles, J.
AU - Healey, E. L.
AU - Holden, M. A.
AU - Jayakumar, P.
AU - Koenig, K.
AU - Lo, G.
AU - Losina, E.
AU - Miller, K.
AU - Østerås, N.
AU - Pratt, C.
AU - Quicke, J. G.
AU - Sharma, S.
AU - Skou, S. T.
AU - Tveter, A. T.
AU - Woolf, A.
AU - Yu, S. P.
AU - Hinman, R. S.
N1 - Funding Information: The authors would like to thank the people with OA who contributed feedback during the Delphi survey development process: Denise Allen (US), Matt Burton (US), Bob Gardner (Australia), Loriann Moreno Muñoz (US), Maria Rosa Papalia (Australia), Julieanne Pofahl (US), and Lou Wissner (US). We also thank the Osteoarthritis Research Society International for assistance with publicizing the Delphi survey. REDCap was supported by UL1TR002489 from the Clinical and Translational Science Award program of the Division of Research Resources, National Institutes of Health. Kelli Allen and Rebecca Cleveland receive support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Core Center for Clinical Research at the University of North Carolina, Chapel Hill (P30AR072580). Kelli Allen receives support from a VA Health Services Research and Development Research Career Scientist Award (19-332) and the Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) (CIN 13-410) at the Durham VA Health Care System. Søren T. Skou is currently funded by a program grant from Region Zealand (Exercise First), and two grants from the European Union's Horizon 2020 research and innovation program, one from the European Research Council (MOBILIZE, grant agreement No 801790) and the other under grant agreement No 945377 (ESCAPE). Kim Bennell is supported by grant funding from the National Health and Medical Research Council, Medical Research Futures Fund and Medibank Private. She has received personal fees from Wolters Kluwer outside the submitted work. J Haxby Abbott is supported in part by a Programme Grant from the Health Research Council of New Zealand (HRC 22/555). Rana Hinman is supported by a National Health & Medical Research Council Senior Research Fellowship (#1154217). Dr. Jayakumar is supported by The Musculoskeletal Institute, University of Texas at Austin. Jillian Eyles is supported by a Sydney Health Partners Research Translation Fellowship and receives royalties from Wolters Kluwer outside the submitted work. Emma Healey is partly funded by the NIHR ARC West Midlands. Saurab Sharma is supported by the International Association for the Study of Pain John J. Bonica Postdoctoral Fellowship. The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Funding Information: The authors would like to thank the people with OA who contributed feedback during the Delphi survey development process: Denise Allen (US), Matt Burton (US), Bob Gardner (Australia), Loriann Moreno Muñoz (US), Maria Rosa Papalia (Australia), Julieanne Pofahl (US), and Lou Wissner (US). We also thank the Osteoarthritis Research Society International for assistance with publicizing the Delphi survey. REDCap was supported by UL1TR002489 from the Clinical and Translational Science Award program of the Division of Research Resources, National Institutes of Health . Kelli Allen and Rebecca Cleveland receive support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Core Center for Clinical Research at the University of North Carolina, Chapel Hill ( P30AR072580 ). Kelli Allen receives support from a VA Health Services Research and Development Research Career Scientist Award ( 19-332 ) and the Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) ( CIN 13-410 ) at the Durham VA Health Care System. Søren T. Skou is currently funded by a program grant from Region Zealand (Exercise First), and two grants from the European Union's Horizon 2020 research and innovation program , one from the European Research Council ( MOBILIZE , grant agreement No 801790 ) and the other under grant agreement No 945377 ( ESCAPE ). Kim Bennell is supported by grant funding from the National Health and Medical Research Council , Medical Research Futures Fund and Medibank Private . She has received personal fees from Wolters Kluwer outside the submitted work. J Haxby Abbott is supported in part by a Programme Grant from the Health Research Council of New Zealand ( HRC 22/555 ). Rana Hinman is supported by a National Health & Medical Research Council Senior Research Fellowship ( #1154217 ). Dr. Jayakumar is supported by The Musculoskeletal Institute, University of Texas at Austin . Jillian Eyles is supported by a Sydney Health Partners Research Translation Fellowship and receives royalties from Wolters Kluwer outside the submitted work. Emma Healey is partly funded by the NIHR ARC West Midlands . Saurab Sharma is supported by the International Association for the Study of Pain John J. Bonica Postdoctoral Fellowship . The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Publisher Copyright: © 2023
PY - 2023
Y1 - 2023
N2 - Objective: To develop sets of core and optional recommended domains for describing and evaluating Osteoarthritis Management Programs (OAMPs), with a focus on hip and knee Osteoarthritis (OA). Design: We conducted a 3-round modified Delphi survey involving an international group of researchers, health professionals, health administrators and people with OA. In Round 1, participants ranked the importance of 75 outcome and descriptive domains in five categories: patient impacts, implementation outcomes, and characteristics of the OAMP and its participants and clinicians. Domains ranked as “important” or “essential” by ≥80% of participants were retained, and participants could suggest additional domains. In Round 2, participants rated their level of agreement that each domain was essential for evaluating OAMPs: 0 = strongly disagree to 10 = strongly agree. A domain was retained if ≥80% rated it ≥6. In Round 3, participants rated remaining domains using same scale as in Round 2; a domain was recommended as “core” if ≥80% of participants rated it ≥9 and as “optional” if ≥80% rated it ≥7. Results: A total of 178 individuals from 26 countries participated; 85 completed all survey rounds. Only one domain, “ability to participate in daily activities”, met criteria for a core domain; 25 domains met criteria for an optional recommendation: 8 Patient Impacts, 5 Implementation Outcomes, 5 Participant Characteristics, 3 OAMP Characteristics and 4 Clinician Characteristics. Conclusion: The ability of patients with OA to participate in daily activities should be evaluated in all OAMPs. Teams evaluating OAMPs should consider including domains from the optional recommended set, with representation from all five categories and based on stakeholder priorities in their local context.
AB - Objective: To develop sets of core and optional recommended domains for describing and evaluating Osteoarthritis Management Programs (OAMPs), with a focus on hip and knee Osteoarthritis (OA). Design: We conducted a 3-round modified Delphi survey involving an international group of researchers, health professionals, health administrators and people with OA. In Round 1, participants ranked the importance of 75 outcome and descriptive domains in five categories: patient impacts, implementation outcomes, and characteristics of the OAMP and its participants and clinicians. Domains ranked as “important” or “essential” by ≥80% of participants were retained, and participants could suggest additional domains. In Round 2, participants rated their level of agreement that each domain was essential for evaluating OAMPs: 0 = strongly disagree to 10 = strongly agree. A domain was retained if ≥80% rated it ≥6. In Round 3, participants rated remaining domains using same scale as in Round 2; a domain was recommended as “core” if ≥80% of participants rated it ≥9 and as “optional” if ≥80% rated it ≥7. Results: A total of 178 individuals from 26 countries participated; 85 completed all survey rounds. Only one domain, “ability to participate in daily activities”, met criteria for a core domain; 25 domains met criteria for an optional recommendation: 8 Patient Impacts, 5 Implementation Outcomes, 5 Participant Characteristics, 3 OAMP Characteristics and 4 Clinician Characteristics. Conclusion: The ability of patients with OA to participate in daily activities should be evaluated in all OAMPs. Teams evaluating OAMPs should consider including domains from the optional recommended set, with representation from all five categories and based on stakeholder priorities in their local context.
KW - Delphi
KW - Implementation
KW - Osteoarthritis
KW - Outcomes
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150844756&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36893979
U2 - 10.1016/j.joca.2023.02.078
DO - 10.1016/j.joca.2023.02.078
M3 - Article
C2 - 36893979
SN - 1063-4584
JO - Osteoarthritis and Cartilage
JF - Osteoarthritis and Cartilage
ER -